logo-loader
viewRyah Medtech Inc

Ryah Medtech CEO Wagner says vaping's place is best reserved for the medicine cabinet

The CEO adds there’s more to vaping than the flavored e-cigarettes that are proving increasingly dangerous to young Americans

People vaping
On Wednesday, President Trump announced a plan to ban flavored e-cigarettes outright in a move to curb teenage vaping

Ryah Medtech Inc CEO Greg Wagner wants people to know that there’s more to vaping than the flavored e-cigarettes that are proving increasingly dangerous to young Americans.

In a post published Thursday titled “Vaping Has A Place In Society, In Your Medicine Cabinet,” Wagner addressed the ongoing vaping crisis and the role of regulation in the sector. 

This comes less than a week after the CDC issued a warning about e-cigarettes and vaping products. As many as 450 people, including six who have died, have been affected by a vaping-related respiratory illness, according to a report from Vox.

On Wednesday, President Trump announced a plan to ban flavored e-cigarettes outright in a move to curb teenage vaping that could have a major impact on the industry.

READ: RYAH takes major step towards completion of its reverse takeover of Prime Blockchain

In the statement, Wagner discussed the role of vaping in medical science and argued that the issues don’t fall at the feet of the technology itself.

“Vaping has been used for hundreds of years as a delivery system for medicine; access to this technology needs to remain available,” Wagner said. “It’s important to distinguish the ongoing benefits of dose-measuring devices and proprietary cartridges designed for precise, patient use and effective treatment versus the inferior counterfeit and black-market products out there.”

The Ryah dry herb vaporizer solves those problems, Wagner said, by allowing patients to precisely regulate dosage and temperature for each vaping session and work with their doctors to find what works best. 

The company also reached out to First Lady Melania Trump, who called e-cigarettes an “on-ramp to nicotine addiction” in a Tweet on Monday.

"We are encouraged to see so many public leaders tackling this health crisis, including the First Lady Melania Trump,” Wagner said. “Ryah would be happy to sit down with her to discuss the data that we have been collecting for years on vaping consumption.”

Wagner added: “It is a critical time to examine ongoing research and insights that will support patients and allow health care providers with access to data necessary to develop regulated, medicines for vaping and protect the public."

The Ryah vaporizer is capable of storing results from vaping sessions to create a picture for doctors and patients of how vaping is working for them and what tweaks — such as cannabis strain, dosage level, frequency or temperature — may need to be made.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ryah Medtech Inc named herein, including the promotion by the Company of Ryah Medtech Inc in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

RYAH Medtech stocks the shelves with its cannabis vaporizer at Maryland...

RYAH Medtech Inc Head of Marketing and Communications Sofiya Kleschuk and Director of Product Operations Jordan Medley join Maryland Sweetspot Dispensary Manager Peter Franklin to tell Proactive Investors the two have joined forces to begin offering RYAH vaporizers to medical...

on 07/11/2019

3 min read